Tryptamine hydrochloride → HCID 86750252, 화합물

HRID 235527

반응식

HRID 235527 반응식
Cl.[NH:2]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[C:4]([CH2:11][CH2:12][NH2:13])=[CH:3]1.[CH2:14]([N:21]([CH3:43])[C:22](=[O:42])[C@@H:23]([N:31]([CH2:39][CH:40]=O)[C:32]([O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:33])[CH2:24][C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1)[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1>>[CH2:14]([N:21]([CH3:43])[C:22](=[O:42])[C@@H:23]([N:31]([CH2:39][CH2:40][NH:13][CH2:12][CH2:11][C:4]1[C:5]2[C:10](=[CH:9][CH:8]=[CH:7][CH:6]=2)[NH:2][CH:3]=1)[C:32]([O:34][C:35]([CH3:37])([CH3:36])[CH3:38])=[O:33])[CH2:24][C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1)[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1

참가 물질

3

반응물 2

HCID 67652Tryptamine hydrochlorideHCID 53842533HCID 53842533, 화합물

생성물 1

HCID 86750252HCID 86750252, 화합물

실험 절차

Prepare by the method of Example 1 using 2-(1H-indol-3-yl)-ethylamine hydrochloride salt (tryptamine hydrochloride salt) (0.197 g, 1.0 mmol) and (S)-N-benzyl-N-methyl-2-[N-(t-butoxycarbonyl)-2-oxo-ethylamino]-3-phenyl-propionamide (0.41 g, 1.0 mmol) to give the title compound: TLC Rf =0.69 (silica gel, 85% chloroform/10% methanol/5% acetic acid).

출처 및 근거

ORD 기록
ord-0003ab746bf54a9f8ba8d633e3decd4c
출처 데이터셋
uspto-grants-1997_01
특허 번호
US05597845

연결된 노트

불러오는 중…